Drug intelligence / Profile preview

ropivacaine + clonidine + epinephrine (The Hawkins Foundation)

Development stage
Unknown
Lead developer
The Hawkins Foundation
Modality
Small Molecules
Administration
Perineural
01

Overview

This combination drug is a local anesthetic cocktail used for regional anesthesia, specifically for ultrasound-guided fascia-iliaca blocks in patients undergoing hip arthroscopy. It consists of ropivacaine, a long-acting amide-type local anesthetic that inhibits sodium ion influx in nerve fibers; clonidine, an alpha-2 adrenergic agonist that acts as an analgesic adjuvant to prolong the duration of the block; and epinephrine, a vasoconstrictor that reduces systemic absorption and extends the local effect. The Hawkins Foundation is evaluating this combination in a Phase 4 clinical trial to compare its efficacy against standard local anesthetic injections for managing post-operative pain.

Brand names
Noropin
Other names
ropivacaineclonidineepinephrineFascia-iliaca block cocktail
02

Targets

ADRB1 (β1)ADRA2A (α2A)ADRA1A (α1A)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on ropivacaine + clonidine + epinephrine (The Hawkins Foundation).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ropivacaine + clonidine + epinephrine (The Hawkins Foundation).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call